CVE-2022-1518: critical vulnerability in Illumina iSeq 100 Instrument
3.2.2 IMPROPER LIMITATION OF A PATHNAME TO A RESTRICTED DIRECTORY ('PATH TRAVERSAL') CWE-22
Published · Updated
E-mail alert when it lands in KEV, gets a public PoC or its score goes up.
28Vexday Risk Score
No sign of exploitation. No public exploitation artifact known so far.
ssvc Trackcvss 10epss 1.7%
LRM contains a directory traversal vulnerability that can allow a malicious actor to upload outside the intended directory structure.
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H
Affected products
Illumina · iSeq 100 InstrumentIllumina · MiniSeq InstrumentIllumina · MiSeq DxIllumina · MiSeq InstrumentIllumina · NextSeq 500 InstrumentIllumina · NextSeq 550DxIllumina · NextSeq 550 InstrumentRelated CVEs — Illumina iSeq 100 Instrument
In the same product, most dangerous first.